Cytokinetics
CYTK | NASDAQ
$62.03
-$0.96 (-1.52%)
At close: Nov 2, 2026, 4:00 PM ET
$62.03
$0.00 (0.00%)
After-hours:
Nov 2, 2026, 4:33 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 31.91M | 19.36M | 17.76M | 1.94M | 66.77M | 1.58M | 16.93M | 463K | 249K | 835K | 1.67M | 378K | 867K | 4.61M | 1.96M | 2.52M | 88.97M | 1.15M | 55.6M | 5.44M | 2.84M | 6.55M |
Cost of Revenue | 2.73M | 2.39M | 2.86M | 2.68M | 2.29M | 99.84M | 93.63M | 84.61M | 79.6M | 81.57M | 84.98M | 82.53M | 83.19M | 79.42M | 75.02M | 62.73M | 57.13M | 45.94M | 43.5M | 48.44M | 36.44M | 31.56M |
Gross Profit | 29.18M | 16.96M | 14.89M | -743K | 64.48M | -98.26M | -76.7M | -84.15M | -79.35M | -80.74M | -83.3M | -82.15M | -82.33M | -74.81M | -73.06M | -60.22M | 31.84M | -44.79M | 12.1M | -43M | -33.6M | -25.01M |
Operating Income | -175.88M | -183.62M | -178.37M | -166.76M | -111.51M | -155.63M | -139.04M | -140.8M | -130.17M | -126.24M | -127.42M | -122.27M | -122.05M | -124.47M | -127.03M | -108.44M | -10.87M | -77.86M | -21.7M | -69.2M | -54.8M | -40.61M |
Interest Income | 13.94M | 11.02M | 11.47M | 10.25M | 13M | 13.7M | 15.01M | 17.05M | 11.55M | 7.91M | 7.59M | 6.84M | 6.78M | 6.43M | 5.92M | 4.14M | 864K | 415K | n/a | 231K | 187K | 290K |
Pretax Income | -198.76M | -206.03M | -183.03M | -306.18M | -134.37M | -161.38M | -150.02M | -160.55M | -143.32M | -135.64M | -136.9M | -129.42M | -128.64M | -131.29M | -137.38M | -142.31M | -19.82M | -89.45M | -30.57M | -76.09M | -61.55M | -47.1M |
Net Income | -198.76M | -206.03M | -183.03M | -306.18M | -134.37M | -161.38M | -150.02M | -160.55M | -143.32M | -135.64M | -136.9M | -129.42M | -128.64M | -131.29M | -137.38M | -142.31M | -19.82M | -89.45M | -30.57M | -76.09M | -61.55M | -47.1M |
Selling & General & Admin | 104.4M | 104.9M | 91.72M | 69.46M | 65.72M | 57.37M | 62.34M | 56.65M | 50.82M | 45.5M | 44.11M | 40.11M | 39.72M | 49.67M | 53.97M | 48.22M | 42.72M | 33.07M | 33.81M | 26.2M | 21.2M | 15.6M |
Research & Development | 97.81M | 95.53M | 101.54M | 99.23M | 112.55M | 99.84M | 93.63M | 84.61M | 79.6M | 81.57M | 84.98M | 82.53M | 83.19M | 79.42M | 75.02M | 62.73M | 57.13M | 45.94M | 43.5M | 48.44M | 36.44M | 31.56M |
Other Expenses | 2.86M | 160K | n/a | -2.68M | -2.29M | -99.84M | -93.63M | -84.61M | -79.6M | -81.57M | -84.98M | -82.53M | -83.19M | -79.42M | -75.02M | -62.73M | -57.13M | -45.94M | -43.5M | -48.44M | -36.44M | -31.56M |
Operating Expenses | 205.07M | 200.58M | 193.26M | 166.01M | 175.99M | 57.37M | 62.34M | 56.65M | 50.82M | 45.5M | 44.11M | 40.11M | 39.72M | 49.67M | 53.97M | 48.22M | 42.72M | 33.07M | 33.81M | 26.2M | 21.2M | 15.6M |
Interest Expense | 34.83M | 33.34M | 30.34M | 26.32M | 24.27M | 22.95M | 22.59M | 22.3M | 24.3M | 17.32M | 17.06M | 14M | 13.37M | 13.24M | 16.27M | 15.77M | 9.81M | 9.31M | 8.87M | 7.12M | 6.94M | 6.78M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 207.8M | 202.97M | 196.12M | 168.69M | 178.28M | 157.21M | 155.97M | 141.26M | 130.42M | 127.07M | 129.09M | 122.64M | 122.92M | 129.09M | 128.99M | 110.96M | 99.84M | 79.01M | 77.3M | 74.64M | 57.64M | 47.16M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 132.09M | 123.27M | 122.02M | 119.98M | 119.46M | 118.5M | 118.08M | 117.69M | 109.24M | 101.92M | 99.07M | 96.07M | 95.76M | 95.16M | 94.68M | 93.76M | 85.73M | 85M | 83.86M | 80.09M | 71.75M | 71.2M |
Shares Outstanding (Diluted) | 132.09M | 123.27M | 122.43M | 119.98M | 119.46M | 118.5M | 118.08M | 117.69M | 109.24M | 101.92M | 99.07M | 96.07M | 95.76M | 95.16M | 94.68M | 93.76M | 85.73M | 85M | 84.09M | 80.33M | 71.75M | 71.2M |
EPS (Basic) | -1.50 | -1.67 | -1.49 | -2.55 | -1.12 | -1.36 | -1.27 | -1.36 | -1.31 | -1.33 | -1.38 | -1.35 | -1.34 | -1.36 | -1.39 | -1.88 | -0.34 | -1.19 | -0.36 | -0.95 | -0.86 | -0.66 |
EPS (Diluted) | -1.50 | -1.67 | -1.50 | -2.55 | -1.12 | -1.36 | -1.27 | -1.36 | -1.31 | -1.33 | -1.38 | -1.35 | -1.34 | -1.36 | -1.39 | -1.88 | -0.34 | -1.19 | -0.36 | -0.95 | -0.86 | -0.66 |
EBITDA | -191.75M | -169.32M | -180.35M | -277.18M | -107.82M | -136.13M | -125.04M | -135.84M | -116.61M | -115.99M | -113.5M | -113.57M | -112.48M | -115.27M | -118.37M | -124.46M | -8.01M | -78.57M | -19.39M | -68.51M | -54.07M | -39.78M |
EBIT | -198.76M | -172.7M | -183.03M | -279.86M | -110.11M | -138.43M | -127.43M | -138.25M | -119.02M | -118.32M | -119.83M | -115.43M | -115.27M | -118.05M | -121.11M | -126.54M | -10.01M | -80.14M | -22.08M | -68.97M | -54.61M | -40.32M |
Depreciation & Amortization | 7.01M | 3.38M | 2.68M | 2.68M | 2.29M | 2.3M | 2.38M | 2.41M | 2.41M | 2.33M | 6.34M | 1.85M | 2.79M | 2.78M | 2.74M | 2.09M | 2M | 1.57M | 2.69M | 462K | 543K | 537K |
Add to Watchlist
Select watchlists to add or remove CYTK